Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | MGAM | O43451 | 1/20 | 0.38 |
| ▸ | SI | P14410 | 1/20 | 0.38 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2618714 | 0.92 | MGLL (0.34) | BRD4KMT2AALDH1A1HPGDATM | |
| SCHEMBL2454952 | 0.86 | TSHR (0.50) | BRD4GAATSHRSMN1; SMN2KMT2A | |
| SCHEMBL6033533 | 0.84 | MGAM (0.43) | BRD4GAAMGAMSIMGAM2 | |
| SCHEMBL14141438 | 0.83 | TSHR (0.54) | BRD4TSHRSMN1; SMN2KMT2AALDH1A1 | |
| SCHEMBL264567 | 0.83 | TSHR (0.48) | TSHRSMN1; SMN2KMT2AALDH1A1HPGD | |
| SCHEMBL24564946 | 0.83 | SMN1; SMN2 (0.40) | BRD4GAAMGAMSIMGAM2 | |
| SCHEMBL13160465 | 0.83 | KMT2A (0.32) | BRD4KMT2AATMMGLL | |
| SCHEMBL19463301 | 0.82 | TSHR (0.47) | TSHRSMN1; SMN2KMT2AALDH1A1HPGD | |
| SCHEMBL29044559 | 0.82 | TSHR (0.47) | TSHRSMN1; SMN2KMT2AALDH1A1HPGD | |
| SCHEMBL905407 | 0.82 | TSHR (0.47) | TSHRSMN1; SMN2KMT2AALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9034661-B2 | Method for producing molecule immobilizing substrate, and molecule immobilizing substrate | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2015-05-19 | — | — | US | disclosed |
| US-20140249076-A1 | AMYLIN-CALCITONIN CHIMERIC PEPTIDES CONJUGATED TO DURATION ENHANCING MOIETIES | ASTRAZENECA PHARMACEUTICALS LP | 2014-09-04 | — | — | US | disclosed |
| US-20100233827-A1 | METHOD FOR PRODUCING MOLECULE IMMOBILIZING SUBSTRATE, AND MOLECULE IMMOBILIZING SUBSTRATE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2010-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140249076-A1 | AMYLIN-CALCITONIN CHIMERIC PEPTIDES CONJUGATED TO DURATION ENHANCING MOIETIES | IAPP, GIPR, VIP | BRD4 4533/4885GAA 437/4885MGAM 1208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.